These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1824192)

  • 1. [Why is there predominance of right heart failure in Chagas' disease?].
    Marin-Neto JA; Andrade ZA
    Arq Bras Cardiol; 1991 Sep; 57(3):181-3. PubMed ID: 1824192
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of QTc interval dispersion in patients with chronic heart failure secondary to Chagas-Hypertensive cardiomyopathy.
    Pinheiro MB; Bestetti RB; Cordeiro JA
    Int J Cardiol; 2007 Sep; 121(1):93-4. PubMed ID: 17126936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure.
    Mady C; Ianni BM; Arteaga E; Salemi VM; de Carvalho Frimm C
    J Card Fail; 2000 Sep; 6(3):220-4. PubMed ID: 10997748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular circulatory support as bridge to heart transplantation in Chagas' disease cardiomyopathy.
    Moreira LF; Galantier J; Benício A; Leirner AA; Cestari IA; Stolf NA
    Artif Organs; 2007 Apr; 31(4):253-8. PubMed ID: 17437492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
    Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
    Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic Chagas cardiopathy as a model for an insight on the pathogenesis of arrhythmogenic right ventricular cardiomyopathy].
    Rossi MA
    Arq Bras Cardiol; 1995 Jul; 65(1):3-5. PubMed ID: 8546592
    [No Abstract]   [Full Text] [Related]  

  • 7. A risk score for predicting death in Chagas' heart disease.
    Kamath SA; Drazner MH
    N Engl J Med; 2006 Dec; 355(23):2489; author reply 2490-1. PubMed ID: 17162762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Predicting heart failure and mortality in chronic Chagas' heart disease. A novel disorder in Spain].
    Acquatella H
    Rev Esp Cardiol; 2008 Feb; 61(2):105-7. PubMed ID: 18364176
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease.
    Marin-Neto JA; Bromberg-Marin G; Pazin-Filho A; Simões MV; Maciel BC
    Int J Cardiol; 1998 Aug; 65(3):261-9. PubMed ID: 9740483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure. Natural history and prognosis].
    Mady C
    Arq Bras Cardiol; 1994 Dec; 63(6):515-7. PubMed ID: 7605239
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial function is preserved in Chagas' heart disease patients without heart failure.
    Consolim-Colombo FM; Lopes HF; Rosetto EA; Rubira MC; Barreto-Filho JA; Baruzzi AC; Rocha NN; Mady C; Irigoyen MC; Krieger EM
    Endothelium; 2004; 11(5-6):241-6. PubMed ID: 15763943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic Chagas' cardiopathy-- use of vasodilators in uncompensated heart failure].
    Marin-Neto JA; Secches AL; Maciel BC; Gallo Júnior L; Terra-Filho J; Manço JC; Amorin DS
    Arq Bras Cardiol; 1982 Apr; 38(4):291-9. PubMed ID: 7168662
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.
    Dourado KC; Bestetti RB; Cordeiro JA; Theodoropoulos TA
    Int J Cardiol; 2006 Apr; 108(3):412-3. PubMed ID: 16520133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
    Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
    Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
    Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
    J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance.
    Corbucci HA; Haber DM; Bestetti RB; Cordeiro JA; Fioroni ML
    Cardiovasc Pathol; 2006; 15(1):18-23. PubMed ID: 16414452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distinctive features of the cardiomyopathy in Chagas disease].
    Palmero HA; Caeiro TF; Iosa DJ
    Medicina (B Aires); 1980; 40 Suppl 1():234-6. PubMed ID: 7453560
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of right ventricular pacing on patients with Chagas cardiomyopathy with chronic systolic heart failure.
    Parra AV; Bestetti RB; Cardinalli-Neto A; Otaviano AP; Nogueira PR
    Int J Cardiol; 2012 Jan; 154(2):219-20. PubMed ID: 22104987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Normal maximal functional capacity in patients with congestive heart failure due to Chagas' cardiomyopathy].
    Mady C; Cardosa RH; Ianni BM; Arteaga E; Koide NS; Silva PR; da Luz PL; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1996 Jul; 67(1):1-4. PubMed ID: 9035458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
    Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
    Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.